Submitted in accordance with the requirements for the degree of PhD The candidate confirms that the work submitted is his own an
![PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial](https://i1.rgstatic.net/publication/299577568_Acute_renal_effects_of_the_GLP-1_receptor_agonist_exenatide_in_overweight_type_2_diabetes_patients_a_randomised_double-blind_placebo-controlled_trial/links/5726f8ef08ae262228b2175b/largepreview.png)
PDF) Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/1b/87/11/e7b901fecbf2d5/imgf000185_0001.png)
WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents
![WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents WO2014134225A2 - Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance - Google Patents](https://patentimages.storage.googleapis.com/be/02/32/ec6eb796770926/imgf000213_0001.png)